Fogorvosi szemle, 2017 (110. évfolyam, 1-4. szám)

2017-09-01 / 3. szám

103 FOGORVOSI SZEMLE ■ 110. évf. 3. sz. 2017. gén eredetű ínyhiperpláziák sebészi korrekciója (esetsorozat). Fogorvosi Szemle. 2013; 106: 61-70. 10. Csiszér E, Soltész I, Füzesi K: Wegener-granulomatosis - Di­agnosztikai kérdések 15 beteg kapcsán. LÁM 2001; 11 (8-9): 566-572. 11. Demirer S, Ozdemir H, Sencan M, Marakoglu I: Gingival hyperpla­sia as an early diagnostic oral manifestation in acute monocytic leukemia: a case report. EurJ Dent 2007; 1: 111-114. 12. Dreizen S, Mccredie KB, Keating MJ, Luna MA: Malignant gingival and skin „infiltrates” in adult leukemia. Oral Surg Oral Med Oral Pathol 1983; 55: 572-579. 13. Dunmire SK, Hogquist KKA, Balfour HH: Infectious Mononucleo­sis. Curr Top Microbiol Immunol 2015; 390: 211-240. 14. Eufinger H, Machtens E, Akuamoa-Boateng E: Oral manifestations of Wegener’s granulomatosis. Review of the literature and report of a case. Int J Oral Maxillofac Surg 1992; 21: 50-53. 15. Ezzat WH, Compton RA, Basa KC, Levi J: Reconstructive Tech­niques for the Saddle Nose Deformity in Granulomatosis With Polyangiitis: A Systematic Review. JAMA Otolaryngol Head Neck Surg 2016 Dec 15. 16. Ferri E, Armato E, Capuzzo P, Cavaleri S, Ianniello F: Early diag­nosis of Wegener’s granulomatosis presenting with bilateral fa­cial paralysis and bilateral serous otitis media. Auris Nasus Lar­ynx 2007; 34 (3): 379-382. 17. Fujimoto S, Watts RA, Kobayashi S, Suzuki K, Jayne DR, Scott DG, et al: Comparison of the epidemiology of anti-neutrophil cy- j toplasmic antibody-associated vasculitis between Japan and the J U. K. Rheumatology (Oxford, England) 2011 ; 50 (10): 1916-1920. ( 18. Gadó K, Z Szabó L, Csákó L, Dómján Gy: Wegener-granulomatosis. | Orv. Hetil 2013; 154: 1083-1095. 19. Gera I és mtsai: Parodontológia tankönyv, Semmelweis Kiadó | 2009; 5. fejezet: 79-111. 7. fejezet: 158-161. 12. fejezet: 335- J 336. 13. fejezet 302. oldal. 20. Gillette WB: Oral manifestations of acute myelomonocytic leuke­mia: a case report and review of the classification of leukemias. Wu J, Fantasia Je, Kaplan R. J Periodontol 2002; 73: 664-668. 21. Guillevin L, Girard T, Mahr A, Noël LH, Cordier JF, Lesavre P, André MH: Are antineutrophil cytoplasmic antibodies a marker j predictive of relapse in Wegener’s granulomatosis? A prospec- | tive study. Rheumatology {Oxford, England) 2001; 40: 147-151. ) 22. Handa R, et al: Wegener’s granulomatosis with gangrene of toes ) Scand. J. Rheumatol 1996; 25: 103-104. 23. Hanisch M, Fröhlich Lf, Kleinheinz J: Gingival hyperplasia as first | sign of recurrence of granulomatosis with polyangiitis (Wegener’s granulomatosis): case report and review of the literature. BMC Oral Health 2016; 17: 33-37. 24. Hernández G, Serrano C, Porras L, Lopez-Pintor R, Rubio L, Yanes J: Strawberry-like gingival tumor as the first clinical sign of Wegener’s granulomatosis. J Periodontol 2008; 79: 1297-1303. 25. Horning GM, Fischer JG, Barker F, Killoy WJ, Lowe JW: Gin­gival fibromatosis with hypertrichosis. J Periodontol 1985; 56: 344-347. 26. Jennette JC, Falk RJ, Gasim AH: Pathogenesis of antineutrophil | cytoplasmic autoantibody vasculitis. Curr Opin Nephrol Hyper- ) tens 2011 ; 20: 263-270. 27. Kallenberg CG: Pathogenesis of ANCA-associated vasculitis, an update. Clin Rev Allergy Immunol 2011 ; 41: 224-231. 28. Karjalainen A, et al: Still another case of Wegener’s granulomato­sis with digital gangrene Scand. J Rheumatol 1996; 25: 339-342. 29. Keglevich T, Benedek E, Gera I: A kálciumcsatorna-blokkolók okozta ínyhyperplasia. Lege Artis Med 1999; 9: 164-168. 30. La Civita L et al: Wegener’s granulomatosis of the elderly: a case j report of uncommon severe gangrene of the feet. Ann Rheum Dis 1995; 54: 328. 31. Lederman D, Lumerman H, Reuben S, Freadman PD: Gingival hy­perplasia associated with nifedipin therapy. Oral Surg 1984; 54: 620-622. 32. Leon G. Clark, BAA, Stanislav N. Tolkachjov, MDB, Alina G. Bridges, Dob, C, Michael J. camilleri, mdb: Pyostomatitis vegetans (PSV)-pyodermatitis vegetans (PDV): A clinicopathologic study of 7 cases at a tertiary referral center. J Am Acad Dermatol 2016; 75: 578-584. 33. Lilly J, Juhlin T, Lew D, Vincent D, Lilly G: Wegener’s granulo­matosis presenting oral lesions. A case report. Oral Surg Oral Med Oral Pathol 1998; 85: 153-157. 34. Lundgren D, Magnunssen B, Lindhe J: Connective tissue altera­tions in gingiva of rats treated with oestrogens and progesteron. Odontological Rev 1973; 24: 49-58. 35. Manchanda Y, Tejasvi T, Handa R, Ramam M: Strawberry gingiva: a distinctive sign in Wegener’s granulomatosis. J Am Acad Der­matol 2003; 49: 335-337. 36. Mohammad AJ, Jacobsson LT, Westman KW, Sturfelt G, Segel­­mark M: Incidence and survival rates in Wegener’s granulomato­sis, microscopic polyangiitis, Churg-Strauss syndrome and pol­yarteritis nodosa. Rheumatology (Oxford, England) 2009; 48: 1560-1565. 37. Moosig, F, Lamprecht P, Gross WL: Wegener’s granulomatosis: the current view. Clin Rev Allergy Immunol 2008; 35: 19-21. 38. Nakamura S, Hiroki A, Shinohara M, et al: Oral involvement in chronic graft-versus-host disease after allogeneic bone marrow transplantation. Oral Surg Oral Med Oral Pathol Oral Radiol En­­dod 1996; 82: 556-563. 39. Napier SS, Allen JA, Irwin CR, Mccluskey DR: ‘Strawberry gums’ - a case of Wegener’s granulomatosis. Br Dent J 1993; 175: 327-329. 40. Nishikawa S, Toda H, Hamasaki A, Kasahora S, et al: Nifedipine­­induced gingival hyperplasia: a clinical and in vitro study. J Peri­­odonfo/1991; 62: 30. 41. Noce CW, Gomes A, Copello A, Barbosa RD, et al. Oral involve­ment of chronic graft-versus-host disease in hematopoietic stem cell transplant recipients. Gen Dent 2011 ; 59: 458-462. 42. Pagnoux C: Updates in ANCA-associated vasculitis. EurJ Rheu­matol 2016; 3: 122-133. 43. Patten SF, Tomecki KJ: Wegener’s granulomatosis: cutaneous and oral mucosal disease. J Am Acad Dermatol 1993; 28: 710-718. 44. Philips RW, et al: Wegener’s granulomatosis and gangrene in the feet. Ann Intern Med 1983; 99: 571-575. 45. Reumaux D, Duthilleul P, Roos D: Pathogenesis of diseases as­sociated with antineutrophil cytoplasm autoantibodies. Hum Im­munol 2004; 65: 1-12.Rostock MH, Fry HR, Turner JE: Severe gingival overgrowth associated with cyclosporin therapy. J Peri­­odontol 1986; 57: 294-299. 46. Ruokonen H, Helve T, Arola J, Hietanen J, Lindqvist C, Hogstrom J: „Strawberry gingivitis” being the first sign of Wegener’s granulo­matosis. EurJ Int Med 2009; 20: 651-653. 47. Savige J, Davies D, Falk RJ, Jennette JC, Wiik A: „Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features”. Kidney International 2000; 57: 846-862. 48. Sepúlveda E, Brethauer U, Fernández E, Cortés G, Mardones C: Oral manifestations as first clinical sign of acute myeloid leuke­mia: report of a case. Pediatr Dent 2012; 34: 418-421. 49. Shiboski CH, Regezi JA, Sanchez HC, Silverman S JR: Oral le­sions as the first clinical sign of microscopic polyangiitis: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 94: 707-711. 50. Siar CH, Yeo KB, Nakano K, Nagatsuka H, Tsujigiwa H, Tomida M, Ng Kh, Kawakami T: Strawberry gingivitis as the first presenting sign of Wegener’s granulomatosis: report of a case. Eur J Med Res. 2011; 16: 331-334. 51. Steward C, Cohen D, Bhattacharyya I, Scheitler L, Riley S, Cala­­mia K, Migliorati C, Baughman R, Langford P, Katz J: Oral mani­festations of Wegener’s granulomatosis: a report of three cases and a literature review. J Am Dent Assoc 2007; 138: 338-348. 52. Watts RA, Mooney J, Skinner J, Scott DG, Macgregor AJ: The contrasting epidemiology of granulomatosis with polyangiitis (We­gener’s) and microscopic polyangiitis. Rheumatology (Oxford, England) 2012; 51: 926-931.

Next

/
Thumbnails
Contents